TERT and glioma: TERT Promoter Mutations: Abnormal reactivation of Telomerase Reverse Transcriptase (TERT) is common in solid tumors, particularly those arising from tissues with low self-renewal capacity, such as melanoma, thyroid cancer, and CNS tumors, including gliomas.